There is increasing evidence linking the incidence of stroke and myocardial infarction to local or systemic infection. During bacterial infection, lipopolysaccharide (LPS) present in the outer membrane of Gram-negative bacteria is released and induces an activation of the endothelium. The vasoconstrictor peptide, endothelin-1 (ET-1), is one of the genes strongly induced by LPS. Here, we show that lipoteichoic acid (LTA), a major component of the outer wall of Gram-positive bacteria is also able to stimulate ET-1 production from endothelial cells.
Bovine aortic endothelial cells were stimulated for 6 h with LPS (from E. coli) or LTA (from S. aureus). Levels of ET-1 present in conditioned media were measured by radioimmunoassay. Results are expressed as mean % change from control ± s.e. mean. Mean basal release was 22.58 ± 1.00 fmol/cm 2 (LTA experiments), n = 12-16 and 25.80 ± 1.37 Endothelial function was assessed in mesenteric arteries of control (n = 9) and uraemic (n = 9) male Wistar rats. Uraemic rats underwent subtotal nephrectomy by staged left cortical resection and right nephrectomy. Control rats were sham operated. Serum creatinine was elevated (mean ± s.d.) in the uraemic (111 ± 11 M) vs control (77 ± 7 M) rats. Tailcuff systolic blood pressure was elevated in uraemic (184 ± 14.6 mm Hg) compared to control (171 ± 7.6 mm Hg) rats after 8 weeks of uraemia fmol/cm 2 (LPS experiments), n = 18-22. We also show that the effects of LPS and LTA are blocked by a proteasome inhibitor, MG115. Co-treatment of bovine aortic endothelial cells with 10 M MG115 and LTA or LPS (1 g/ml) for 6 h reduced by 48% and 64% the amount of ET-1 released in response to LTA and LPS respectively.
Increased production of ET-1 is thus likely to be a feature of infections, irrespective of the type of bacteria involved (Gram-positive or negative). In addition, these results suggest that in endothelial cells the increased ET-1 synthesis induced by bacterial cell wall components is mediated by a common intracellular pathway, whose activation is dependent on the activity of the proteasome. These findings provide a further link between ET-1 and cardiovascular pathologies.
(P = 0.037). Distal second order mesenteric arteries (295 m) were dissected, cannulated and pressurised to 60 mm Hg on a myograph. Lumen diameter was continuously measured by a video dimension analyser. Constrictor responses to phenylephrine (10 −7 -10 −5 M) before and after nitric oxide synthase inhibition by L-NAME (10 −4 M) were assessed. Responses to the endothelial dependent (acetylcholine, 10 −9 -10 −6 M) and independent (nitroprusside, 10 −10 -10 −4 M) dilators were deter-mined in vessels preconstricted by 50% with phenylephrine, before and after nitric oxide synthase inhibition. Response curves were compared between groups by analysis of variance, and significance level was taken as P Ͻ 0.05. Responses to phenylephrine and nitroprusside, in the presence and absence of nitric oxide synthase inhibition, were the same Ouabain: pure and simple?
SD Gillingwater, AN Butt and R Swaminathan Department of Chemical Pathology, GKT Medical and Dental Schools, St. Thomas' Campus, London SE1 7EH, UK
Endogenous sodium transport inhibitors have been characterised using cardiac glycosides such as ouabain. The continuing search for ouabain-like substances, therefore, utilises ouabain as a reference compound in many, if not all, experiments. Ouabain inhibits Na + , K + -ATPase via a binding site located on the ␣ sub-unit. The enzyme has a catalytic ␣ subunit involved in the splitting of ATP and various isoforms exist (␣1, ␣2 and ␣3). Sensitivity of Na + , K + -ATPase to ouabain differ between tissue and between species. This has been attributed to the different distributions of isoforms. However, it is feasible that the different sensitivity to ouabain may also reflect differences in ouabain itself. In the present study we show that natural ouabain may exist as different isomers.
Commercially available ouabain (Sigma) was chromatographed using HPLC with diode array detector (DAD), with a linear methanol gradient. Fractions were collected every minute, evaporated to dryness and analysed by radioimmunoassay (RIA)
Secretion of ouabain-like substance (OLS) by human adrenocortical cell line (H295R)
BP Tennant, AN Butt and R Swaminathan Department of Chemical Pathology, GKT Medical and Dental School, St Thomas' Campus, London SE1 7EH, UK Recent evidence suggests that the endogenous sodium transport inhibitor in various mammalian tissues and biological fluids is ouabain or an isomer of ouabain. We have previously shown in the rat that adrenal glands have the highest content of OLS. In the present study, secretion of OLS by a human adrenal cortex cell line (H295R) has been examined.
Cell monolayers were cultured in Dulbecco's Modified Eagle's Medium/Ham's-F12 medium (1:1 v/v). At confluence, cells were incubated with 20 ml of secretion media (Krebs-Ringer solution supplemented with glucose) with or without angiotensin II (AII) (10 nM) over 4 h, and OLS was measured by a ouabain RIA developed in our laboratory.
Results are shown in Table 1 . OLS secretion from control cells tended to increase over the study period. AII stimulated cells showed a significant increase in OLS secretion.
OLS from secretion media was extracted and purified by high performance liquid chromatography (HPLC) using a C18 silicas column in a step up gradient system of 16% to 80% acetonitrile/water between groups. Dilation to acetylcholine was significantly decreased (P Ͻ 0.005) by L-NAME, however no difference between control and uraemic groups existed for the acetylcholine dose response curves before or after L-NAME. It is concluded that nitric oxide mediated endothelial dysfunction is not present in mild experimental uraemia.
and Na + ,K + -ATPase inhibition. The chromatograph showed only one peak, but two compounds were detected by RIA and both showed an ability to inhibit Na + ,K + -ATPase using NADH linked colourimetric assay, but differed in their ability to absorb at 220 nm. Peak one eluted at 11-12 min and is UV active, but peak two, eluted 15-16 min, is non-UV active. Injection of a known mass (8 mg) of ouabain resulted in 1 mg and 6.65 mg peak one and peak two, respectively. The relative abundance of these two compounds was also investigated by UV spectroscopy using the published max , extinction coefficient, of ouabain. A 22 mg/L solution (theoretical Abs. 1.0) produced an actual Abs. of 0.157 suggesting the ratio of peak one and peak two to be 1:8 (w/w). Further investigations using tandem mass spectrometry has also indicated different fragmentation patterns (unpublished data). This is a novel phenomenon which has implications because ouabain is widely used as a pharmacological tool. A recent report (Nelson M et al. J Physiol 1997; 503: 259-264) has suggested that activation of the swell induced chloride (I swell ) current may be important in the myogenic response of cerebral arteries. Most arteries do not exhibit basal tone when mounted as an unpressurised isometric preparation on the wire myograph, but rat small coronary arteries (internal diameter 200-350 m) do develop basal active tension when mounted on a wire myograph. Furthermore, when an inhibitor of nitric oxide synthase, N G -L-nitro-arginine methyl ester (L-NAME, 10 −4 M), is applied they develop a large amount of active tension over a period of about 30 min (1.34 ± 0.08 mN/mm, n = 17). This contraction is sustained for at least 90 min but is greatly reduced (94% ± 2%) by the calcium channel blocker nicardipine (10 −6 M). We have investigated the effects of 4,4Ј-diisothiocyanato-stilbene 2,2Јdisulphonic acid (DIDS) and tamoxifen, blockers of the I swell current (Okada Y. Am J Physiol 1997; 273: C755-C789), on the L-NAME induced contraction in rat coronary arteries.
Platelet sodium/hydrogen exchanger activity and renal acid excretion in normotensives and hypertensives 
Background
Increased activity of sodium/ hydrogen exchange provides a potentially important mechanism for the development of hypertension. The aims of this study were to compare platelet sodium/hydrogen exchanger activity and renal acidbase excretion in normotensives and hypertensives.
Methods Platelet intracellular pH (pHi) was measured using the fluorescent dye BCECF to monitor intracellular pH. Sodium/hydrogen exchanger activity was estimated from the recovery of pHi clamped to 6.25 with nigericin. Normotensives had supine blood pressures of Ͻ140 and Ͻ90 mm Hg; those with essential hypertension had blood pressures Ͼ150/95 mm Hg with no known secondary cause. Measurements of platelet intracellular pH and sodium/hydrogen exchanger activity were made on 26 normotensives (10 female, 16 male) and 25 hypertensives (5 female, 20 male). Renal acid excretion was measured in 42 normotensives (13 female, 29 male) and 48 hypertensives (16 female, 32 male). All subjects were on their usual dietary sodium intake. Statistical analysis was by two-way analysis of variance for gender and blood pressure status. Group values are means ± s.d. and a P value of Ͻ0.05 was taken as statistically significant.
Results
There were no significant differences in DIDS caused a concentration dependent relaxation of L-NAME induced tension in rat isolated small coronary arteries, for example 75 M DIDS caused a relaxation of 61% ± 12%, time to plateau was 12 min ± 3 min (n = 5), 300 M DIDS caused a relaxation of 91% ± 6% (n = 4). Another chloride current blocker, tamoxifen (10 M), initiated a relaxation of 85% ± 7% after an exposure of 30 min. Addition of an equivalent volume of vehicle, dimethyl sulfoxide (10 l), did not cause any relaxation over a 30-min period. DIDS (300 M) did not affect/relax a contraction to 60 mM potassium solution. In the presence of the potassium channel blockers glybenclamide (1 M) and TEA (10 mM) 300 M DIDS caused a relaxation of 71% ± 12% (n = 4).
Selective blockers of the chloride current I swell vasodilate rat isolated small coronary arteries at concentrations similar to those at which they inhibit the chloride current in single vascular smooth muscle cells and therefore these chloride currents may be involved in regulating myogenic tone.
platelet pHi between the normotensive (n = 26) and the hypertensive (n = 25) group: pHi 7.21 ± 0.14 and 7.18 ± 0.16, respectively. The pHi recovery after acidification was sodium-dependent and inhibited by N-hexamethylene amiloride. Comparison of kinetic constants showed no significant differences between the normotensive and the hypertensive group: values for rate constants and initial velocities were 0.24 ± 0.04 s , 0.16 ± 0.03 dpHi/s for the hypertensives, respectively; there were also no significant differences in proton fluxes. Indices of urinary acid excretion (urinary ammonium, titratable acidity and pH) for the normotensive females and males were: urinary ammonium, 24.0 ± 8.0/26.7 ± 9.9; titrable acidity, 24.6 ±11.4/ 29.9 ± 16.0; and urinary pH, 5.95 ± 0.6/5.91 ± 0.56, respectively; average values for the hypertensive group were not significantly different from those in the normotensives.
Conclusions These investigations highlight the difficulties in identifying subgroups of patients with raised sodium/hydrogen exchanger activity and raise the issue of methodological problems in the assessment of cellular sodium/hydrogen exchanger activity and renal hydrogen handling in humans. Background Recently a common polymorphism in exon 7 of the endothelial nitric oxide (NO) synthase gene (894 G→T) was reported to be a strong risk factor for coronary artery disease with homozygous genotype (NN) frequency of 36% in case vs 10% in controls (Hingorani et al. Circulation 1997; suppl: SS-3050) . As endothelial NO maintains systemic vascular tone and basal cerebral blood flow in man and reduces platelet adherence and aggregation, we hypothesised that it could also be a risk factor for cerebrovascular disease and hypertension.
Methods Three hundred and sixty-one consecutive Caucasian patients presenting with ischaemic stroke or TIA (mean age 65.7 (s.d. 11.90 years) to a neurological cerebrovascular disease service were studied and compared with 236 normal Caucasian controls (mean age 64.6 (s.d. 8.9 years). DNA was extracted from leucocytes and the 894G→T substitution was identified by the use of polymerase chain reaction and restriction enzyme digestion by Ban II which cuts the normal variant (n). There is burgeoning interest in the ubiquitous biological functions of nitric oxide. In view of acknowledged limitations of both pharmacological inhibitors of nitric oxide synthesis and nitric oxide donor compounds, the ability to prepare reproducible standard solutions of this highly labile biological mediator, in the laboratory, represents an invaluable pharmacological tool in the investigation of its physiological roles. There are many problems associated with accurately measuring and preparing such a labile compound, and as yet an accepted standardised technique has yet to emerge from a vast associated literature. Here we suggest a 'clean', relatively simple and reproducible method for the preparation of nitric oxide standard solutions for biological application. The methodology described employs discrete volumes of nitric oxide gas and incorporates an anion exchange resin into the preparation of saturated nitric oxide stock solution to extract contaminating nitrite and nitrate.
All apparatus must be gas tight and thoroughly flushed with nitrogen gas. A saturated nitric oxide stock solution (approximately 2 mM) is prepared type frequency between patients and controls (13% vs 15.3%, P = 0.44) or in N-allele frequency (39% vs 37%, P = 0.57). There was also no association between the NN genotype frequency and hypertension (normotensive 38/284[13.4%] vs hypertensive 45/323 [14.4%], P = 0.5). In addition there was no association with genotype when only patients with stroke (not TIA) were considered (n = 289, NN genotype frequency 13.8%), or when individuals р65 years were considered (NN cases 16/154 (10.4%), Controls 19/122 (15.6%), P = 0.2). Furthermore there was no association with any particular stroke subtype: NN frequency lacunar stroke 10/75 (13.3%), large vessel atheroma 15/105 (14.3%), cardioembolic/unknown 18/151 (11.9%), tandem 4/30 (13.3%), chi square P = 0.68. In comparison hypertension (P Ͻ 0.0001), smoking (P Ͻ 0.00001) and diabetes (P = 0.003) were independently associated with CVD risk.
Conclusion
We were unable to establish an association between exon 7 polymorphism, cerebrovascular disease and hypertension. employing a 500 ml saline i.v. bag which has been flushed with nitrogen to exclude oxygen, filled with 250 ml de-oxygenated distilled water and containing 30 milli-equivalents of anion exchange resin. The remaining head space is filled with nitric oxide gas (BOC, 99.9% purity). The bag is then left overnight to equilibrate at 5°C in the fridge to yield an approximately 2 mM stock solution of NO. Serial dilutions of the saturated nitric oxide stock solution are then prepared from de-oxygenated vacutainers tubes containing 9 ml of distilled water. The vacutainer tubes are purged of oxygen for 40 min by bubbling with nitrogen over ice. To ensure a gas-tight seal on the vacutainer tubes tops were coated in silicone grease and wrapped in parafilm. One millilitre of the 2 mM stock solution was then serially diluted through the vacutainer tubes employing a gas-tight syringe rinsed with nitrogen gas. Preparation of the NO solutions is validated employing a Sievers 270A Chemiluminescent NO Analyser.
This methodology, with careful technique, allows the preparation of reproducible standard solutions of nitric oxide for pharmacological application. Background Accentuated platelet function has been reported in patients with acute stroke. Platelet function is also increased in hypertension. Changes in the platelet precursor cell, the bone marrow megakaryocyte (MK), are associated with changes in platelet function. Measurement of MK parameters in the acute phase of stroke probably reflects pre-stroke MK and platelet indices. Since about half of patients with stroke present with a history of hypertension, it is likely that platelet hyperfunction precedes the stroke in these patients. The purpose of this study was to assess platelet and megakaryocyte parameters in patients with acute stroke.
Methods Forty-eight consecutive patients with the diagnosis of acute stroke were studied within 3 days of the onset of symptoms. Twenty-four control subjects were also recruited. Platelet size (mean platelet volume, MPV) and platelet count (PC) were measured by standard laboratory techniques. MK para- Background Arterial stiffening is the principal cause of increasing systolic blood pressure (BP) with advancing years and in patients with arterial hypertension (HTN). In patients with stiffened arteries, reduction in wave reflection decreases aortic systolic BP augmentation.
Aims In this pilot study the aims were (1) to investigate the use of radial artery applantation tonometry for the assessment of central aortic pressure augmentation and, (2) to examine a group of essential HTN patients who were either receiving antihypertensive drug treatment or were on non-pharmacological treatment.
Methods Thirty-three patients with essential HTN who were pharmacologically treated (mean ± s.e. age 58.8 ± 2.3 years, BP 150/84 ± 4/2 mm Hg, M/F 12/21), nine patients who were non-pharmacologimeters were measured by flow cytometry. Bleeding time (BT) was performed using the Simplate II device. Of the patients, 41 had MPV, 47 had PC and 18 had BT measured. The corresponding numbers for controls were 24, 19 and 11 respectively. Twenty-three patients and 13 controls had bone marrow aspirated from the posterior iliac crest, which was then processed for MK analysis. The patients were further divided into those with a history of hypertension (HT strokes; n = 24) and those with no history of hypertension (NT strokes; n = 24).
Results See Table 1 .
Conclusion MPV, MK ploidy (DNA content), size (FSC) and granularity (SSC) are increased, whereas PC and BT are decreased in patients with acute stroke compared with controls. These changes appear to be largely confined to those patients with pre-existing hypertension and are probably important in the pathophysiology of stroke.
cally treated (age 46.4 ± 5.0 years, BP 143/92 ± 4/3 mm Hg, M/F 5/4) and seven normotensive controls (age 34.0 ± 3.5 years, BP 119/78 ± 3/2 mm Hg, M/F 2/5). Non-invasive applantation tonometry of the radial artery using the PWV™ Medical Blood Pressure Analysis Systems.
Results Augmentation index was significantly increased in pharmacologically treated patients as compared to non-pharmacologically treated hypertensives and normotensive subjects (89.0 ± 3.1, 74.4 ± 7.8 and 60.3 ± 2.3 respectively (P = 0.0006 by ANOVA). In univariate analysis augmentation index was significantly associated with age and systolic BP (positively) and with height (negatively). In multivariate analysis, augmentation index was significantly associated with systolic and diastolic BP. Method Twelve hypertensive patients and 12 controls were studied. Megakaryocytes were recovered from posterior iliac crest bone marrow aspirates. Megakaryocyte and platelet adhesion molecule parameters were measured using flow cytometry. Mean platelet volume (MPV) and count were measured using usual laboratory techniques. Bleeding time measurements were done by forearm incision using a Simplate II R bleeding time device. Losartan (50 mg), an angiotensin II receptor antagonist, was used to reduce blood pressure in seven hyperten- Background Hypertension (HPT) is associated with abnormalities in calcium metabolism (such as hypercalciuria and secondary hyperparathyroidism). Cross-sectional studies have reported an independent association between HPT and prevalent kidney stone (KS) disease.

Hypertension and incidence of kidney stones in men
Objective To examine whether HPT predicts the incidence of KS disease over 7 years among middleaged men.
Design and methods
The Olivetti Heart Study is a longitudinal study of middle-aged working men in southern Italy. A total of 424 men with negative history of KS (age 45.8 ± 7.4 years [M ± s.d.]; BMI 26.0 ± 3.0 kg/m 2 ; BP 124.8/86.0 ± 16.4/10.2 mm Hg; serum creatinine 97 ± 9 mM), who were seen in 1987, were re-examined in 1994. HPT was defined necessarily be associated with normalization of augmentation index. Further studies are needed to look at the differential effects of various antihypertensive drugs on pulse wave reflection. sives. After 6 weeks the measurements were repeated.
Conclusion
The MPHA is shifted in a prothrombotic direction in hypertension. Megakaryocyte ploidy, platelet size and GpIIIa expression are increased and bleeding time is shortened. The reduced platelet count suggests that increased platelet destruction and turnover may cause this shift. The antihypertensive, losartan, reverses some of these prothrombotic changes by reducing BP or by some other antiplatelet mechanism. These changes may explain, in part, why treatment of hypertension is associated with reduced vascular mortality.
as BP Ͼ 160 and/or 95 mm Hg or on drug therapy at baseline. Anthropometry, BP and history of KS were evaluated both at baseliner and at the 7-year followup visit. Occurrence of KS was defined as radiological or echographic evidence or documented passage of one or more stones.
Results At baseline 89/424 (21%) had HPT and 20 were on drug treatment. After 7 years 45 (10.6%) incident cases of KS were detected. The majority (39) had a documented passage of one or more stones. The incidence of KS was higher in hypertensive than in normotensive men (16.9 vs 9.0%; P = 0.03 Background Overweight predicts blood pressure (BP) levels and it may explain cross-cultural differences in the prevalence of hypertension around the world. However, it is not clear whether these differences in BP are fully explained by differences in obesity and whether the relationships between body weight (WT) and adiposity and BP operate similarly in these groups.
Objectives To estimate the contribution of WT and adiposity to BP across ethnic groups and to compare the magnitude of the relationship between measures of body mass and BP.
Methods Population-based cross-sectional study of 1578 men and women living in South London (aged 40-59 years) of South Asian (SA: n = 505), African (Af: n = 549) and Caucasian (C: n = 524) ancestry, randomly selected from general practices. WT, a significant predictor of KS disease, probably through the greater calcium losses seen in hypertensive people.
The frequencies were similar in white subjects and those of African descent (II, ID, DD: 18.4%, 49.6%, 32.0% for whites; 18.4%, 50.5%, 30.9% for those of African descent, respectively), but there was a much higher frequency of the I allele in those of South Asian origin (II, ID, DD: 39.8%, 41.8%, 18.3%; chi square = 77.6; P Ͻ 0.0001). There was no association between the I/D polymorphism and impaired glucose metabolism in any ethnic group. There were also no significant associations between the I/D polymorphism and hypertension in white subjects and in those of South Asian origin. This contrasts with a highly significant association between the D allele and hypertension in women (OR = 2.54; 95% CI 1.38-4.65; P = 0.003) but not in men (0.79; 0.36-1.72) of African descent (test for differences between sexes P = 0.023).
Conclusions
These observations provide estimates of the frequency distribution of the ACE I/D polymorphism in white subjects, in people of African descent and in people of South Asian origin. Moreover, these results highlight the potential importance of gender-dependent interactions between genetic background and expression of hypertensive phenotype.
height, waist (W) and hip (H) circumferences were taken. BP was measured with an automated procedure. An administered questionnaire established ethnicity and drug therapy.
Results BP levels were higher in Af than SA and C (135.0/87.8 vs 130.1/85.2 and 127.7/82.0 mm Hg in men; 135.0/84.9 vs 127.2/79.6 and 123.1/77.0 mm Hg in women). These differences in BP 'between' groups remained after adjustment for age, drug therapy and either BMI or W:H ratio. BP increased with increasing BMI and W:H ratio in both men and women 'within' each ethnic group. Multiple regression coefficients (adjusted for age, therapy and ethnic group) in men were 0.82(0.18) mmHgSBP/kg*m 2 (P Ͻ 0.0001) for BMI and 5.9(1.2) mmHgSBP/0.1 unit (P Ͻ 0.0001) for W:H. In women a significant interaction with BMI and ethnicity (P = 0.04) suggests that the effect is steeper in C C-type natriuretic peptide (CNP) is a potent, endothelial-derived relaxant and growth-inhibitory peptide and endothelial dysfunction is well recognised in patients with cardiovascular disease. We measured circulating levels of CNP in 20 healthy subjects (14 male; 18 white, 2 Asian), average supine blood pressure (BP) 126/76 ± 3/2 mm Hg (mean ± s.e.m.); 13 patients 2 weeks after orthotopic cardiac transplantation (OCTx: 11 male; 12 white, 1 Asian), BP 124/75 ± 4/2 mm Hg; and 46 patients 1-13 years after OCTx (40 male; 43 white, 3 Asian), BP 148/96 ± 3/2 mm Hg. Results were compared by unpaired t-tests, after logarithm transformation of data if required. In subjects 2 weeks after OCTx, plasma CNP was raised four-fold (2.64 ± 0.26 pmol/l) compared with values in healthy subjects (0.64 ± 0.04 pmol/l; P Ͻ 0.001). In cardiac transplant recipients studied 1-13 years after transplant, the mean plasma CNP was lower, but still significantly raised (1.15 ± 0.07 pmol/l) when compared with values in healthy sub-A randomised double-blind study of medium term dietary salt reduction on blood pressure in cardiac transplant recipients We have previously shown that high dietary salt intake is typical of cardiac transplant recipients (CTR). The effects on blood pressure of sustained salt reduction in CTR are unknown.
We studied 20 orthotopic CTR (mean age 54 ± 2 (s.e.m.) years, all male, 73 ± 8 months post transplant, mean ejection fraction 74 ± 1%). All 20 were but do not explain the differences in BP 'between' co-resident ethnic groups. The strength of the relationship is attenuated in women from ethnic minorities. This finding may have important etiological and public health implications as advice to lose weight may not lead to the same BP lowering effect in different ethnic groups.
jects (P Ͻ 0.001). In contrast, blood pressure was only increased in the group studied late after transplant (systolic, diastolic, P Ͻ 0.001 vs healthy controls and early transplant group). CNP increased significantly with systolic BP in the late OCTx group (r = 0.31, P = 0.036, N = 46). In the late OCTx group, CNP was raised in 13 patients with cardiac allograft angiographic coronary artery disease (1.4 ± 0.2 pmol/l; P = 0.032) compared with the 33 patients without angiographic coronary allograft disease (1.06 ± 0.07 pmol/l). This difference remained significant after adjusting for systolic pressure (P = 0.045).
These findings show that plasma CNP is raised both early and late after cardiac transplantation, and is significantly higher in patients with angiographic post-transplant coronary artery disease. CNP may be important as a circulating or local hormone involved in vascular contractile function and in the pathophysiology of cardiac allograft vasculopathy after heart transplantation.
on cyclosporin and azathioprine, none were taking steroids. In addition to their usual treatment, they were advised to reduce their salt intake and in a double-blind randomised crossover study received either 100 mmol NaCl (Slow Sodium, Novartis) or matched placebo daily for each of two 1-month periods.
Initial dietary sodium intake (assessed by 24-h urinary Na excretion) was 170 ± 13 (range 77-267) mmol per 24 h. Initial clinic blood pressure was 141/97 ± 4/2 mm Hg. Twenty-four hour ambulatory blood pressure (Spacelabs 90207), 24-h urinary Na excretion and plasma ANP and BNP were measured at the end of each 1-month period.
There was a significant fall in 24-h mean systolic and diastolic blood pressure on placebo compared to Slow Sodium (Table) . These effects were not explained by changes in plasma ANP and BNP. Our results suggest that high dietary salt intake may contribute to the development of hypertension after cardiac transplantation, and that sustained reduction in intake results in improved blood pressure control.
Blood pressure control and multiple risk factor modification in patients with ischaemic heart disease Preventative cardiology is now focusing on the total level of risk in individuals. This has led to the use of risk factor tables such as the Framingham table to identify individuals at increased risk. The modification of risk factors (blood pressure, cholesterol) has been proven to significantly reduce cardiovascular morbidity and mortality.
The aim of the present study was to assess the level of detection and management of major risk factors in patients who had died of ischaemic heart disease (ICD 10 coding I20-I25) in a 2-year period (April 1995 -March 1997 at St. George's Hospital. The assessment of risk factors was carried out according to a pre-set questionnaire.
Out of 317 patients fulfilling the entry criteria only 158 were residents of Merton, Sutton and Wandsworth and less than 85 years old. Of these, 121 had been reviewed at St George's prior to death. The mean age of the population under study was 73 years (range 45-85). 82 were men, 39 women and 22% belonging to ethnic minority populations: 89% of these patients had been seen in a general medical clinic prior to death. Blood pressure was recorded Effect of salt intake on renal excretion of water in patients with essential hypertension There is a controversy about the relationship between salt intake, water intake and blood pressure. Studies in animals have demonstrated that a high salt intake increases urine volume with an increased water intake. However, in man, it is less clear how far salt intake determines fluid intake and furthermore, if there is a relationship between fluid intake and blood pressure, how far is it confounded by differences in salt intake.
Two studies were carried out. In the first, 634 patients with essential hypertension on no treatment had measurements of 24-h urinary sodium and vol- in 95% (95% CI, 89-99%) of the population. Of those 58% (49-69%) were hypertensive. Of the hypertensives 22% (10-32%) were not on any medication and 30% (19-45%) who were on medication had a blood pressure у160/95 mm Hg. Only 52% (42-74%) of the patients with known IHD prior to the acute event and 44% (31-58%) of those without IHD had blood cholesterol measured. There was no significant detectable improvement in the level of detection and management of these risk factors when patients with multiple risk factors (FH of angina, PVD, stroke) were evaluated with 51% (40-63%) having had their cholesterol measured. Of the same group, 57% (43-69%) were hypertensive, of which 13% (3-24%) were not on medication and 33% (18-48%) were on medication and had a blood pressure у169/95 mm Hg. We conclude that the recording of risk factors was inadequate and their management suboptimal. Future management will require much more aggressive intervention so that avoidable deaths from ischaemic heart disease can be prevented.
ume on their usual sodium intake. There was a significant correlation between urine volume and urinary sodium excretion b(l/mmol) = 0.0045, r = 0.38, P Ͻ 0.001. This correlation was also significant when corrected for age, gender, race, body weight and other potential confounders. A difference in salt intake from 275 mmol to 20 mmol predicted a urine volume change of 1148 ml.
In the second, 104 patients with essential hypertension were studied on their normal diet, a high sodium intake of 350 mmol/day for 5 days and a low sodium diet of 10 mmol/day for 5 days with no advice about fluid intake. On the normal diet, the mean 24-h urinary volume was 1559 ml with a urinary sodium excretion of 147 mmol/24 h. After 5 days on the high-salt diet, urinary volume increased to 2155 ml (urinary sodium 274 mmol/24 h). After 5 days on the low-salt diet, urinary volume decreased to 1312 ml (urinary sodium 21 mmol/24 h). There was a highly significant correlation between the reduction in urinary volume on going from the high to the low-salt diet and the decrease in urinary sodium excretion (r = 0.50, P Ͻ 0.001). This correlation was still significant when corrected for age, gender, race, the change in body weight and other potential confounders. The average reduction in urine volume was 843 ml (P Ͻ 0.001) from the high to the low-salt diet, which was very similar to the predicted change derived from the larger number of hypertensive subjects studied on their usual diet.
In hypertensive patients on their usual diet, the greater the salt intake the greater the renal excretion Effect of sodium intake on blood pressure and the renin system in black and white hypertensive patients FJ He, ND Markandu, GA Sagnella and GA MacGregor Blood Pressure Unit, St. George's Hospital Medical School, London, UK Aim The aim of this study was to investigate the differences in blood pressure response to alteration of sodium intake between black and white hypertensive mechanisms and to elucidate whether changes in the reactivity of the renin system may account, in part, for this.
Methods
One hundred and four patients with essential hypertension were studied on a high sodium intake of 350 mmol/day for 5 days and low sodium intake of 10 mmol/day for 5 days.
Results There were 33 male and 38 female white subjects (mean age: 49 years) and 15 male and 18 female black subjects (mean age: 44 years). The fall in blood pressure on changing from the high sodium to the low sodium diet was 17/6 mm Hg in whites and 22/10 mm Hg in blacks. Compared with whites, black patients had a 7 mm Hg greater fall (P Ͻ 0.05) in systolic blood pressure and 4 mm Hg greater fall (P = 0.068) in diastolic blood pressure (adjusted for age and blood pressure on the normal diet) with similar changes in urinary sodium excretion. With of fluid. When salt intake is decreased from a high to a low sodium intake there is a fall in urine volume. This difference in urine volume is very similar to the difference seen in free living individuals. These results clearly demonstrate that salt intake is one of the major factors controlling urine volume and therefore fluid intake and that the difference in urine volume between individuals and between populations is likely to be more related to differences in salt intake rather than any direct relationship between urine volume and blood pressure. Our findings are also important in that they clearly document a quantitative relationship between salt intake and fluid intake and have major implications for the soft drink industry. For instance, if the COMA cardiovascular recommendations to reduce salt intake from 9 to 6 grams were implemented, the fluid intake in the whole population would fall by approximately 250 ml/day (ie, equivalent to one soft drink per person per day). sodium restriction plasma renin activity rose from 0.65 to 3.03 ng/ml/hr in whites, whereas in black subjects it only rose from 0.3 to 1.28 ng/ml/hr (P Ͻ 0.001 blacks vs whites). From the high to the low sodium diet, plasma angiotensin II increased by 31 pmol/l in whites and by 12 pmol/l in blacks (P Ͻ 0.05 compared to whites), plasma aldosterone rose by 499 pmol/l in whites and by 256 pmol/l in blacks (P Ͻ 0.01). Significant inverse correlations were obtained for all patients between the fall in systolic blood pressure with the low sodium diet and (1) the plasma renin activity and angiotensin II on the normal diet; (2) the plasma renin activity, angiotensin II and aldosterone on the low-salt diet; (3) the rise in plasma renin activity, angiotensin II and aldosterone on going from the high to the low sodium diet.
Conclusions
Hypertensive black patients have a greater fall in blood pressure with a short term reduction in salt intake compared to white patients. This greater fall in blood pressure in black patients is, at least in part, due to their less responsive reninangiotensin-aldosterone system.
